Canadian Medical Association welcomes Dr. Margot Burnell as new president Français
OTTAWA, ON, May 31, 2025 /CNW/ - New Brunswick's Dr. Margot Burnell is now the president of the Canadian Medical Association (CMA), following an installation ceremony at its annual general meeting today.
An oncologist for more than three decades at the Saint John Regional Hospital, Dr. Burnell has seen the impact of a health system under pressure. During her address to physician-colleagues, Dr. Burnell emphasized her commitment to improve access to care as a core issue of her year-long mandate. She is also eager to advance Indigenous reconciliation in health care, strengthen Canada's health workforce, reduce physicians' paperwork and improve physician well-being.
"Canadians deserve a health system that is there for them when they need it," she says. "I strongly believe that ideas and lived experience from patients, physicians and others at the front lines are critical to building a future for health care that Canadians can take pride in."
The president of the CMA is elected by members from a different province or territory every year and speaks on behalf of Canada's physicians to policy-makers, partners, media and Canadians.
With the start of Dr. Burnell's presidency, Dr. Joss Reimer of Winnipeg becomes the CMA's past president.
Dr. Bolu Ogunyemi named CMA president-elect
Dr. Bolu Ogunyemi became president-elect at today's AGM. Dr. Ogunyemi practises medical dermatology in St. John's, NL, and has maintained a visiting specialist clinic in Labrador City since 2018. In addition to numerous leadership roles at Memorial University of Newfoundland's Faculty of Medicine, including the inaugural Assistant Dean of Social Accountability (2020–23), he has served on the Newfoundland and Labrador Medical Association Board of Directors.
About the CMA
The Canadian Medical Association leads a national movement with physicians who believe in a better future of health. Our ambition is a sustainable, accessible health system where patients are partners, a culture of medicine that elevates equity, diversity and wellbeing, and supportive communities where everyone has the chance to be healthy. We drive change through advocacy, giving and knowledge sharing – guided by values of collaboration and inclusion.
SOURCE Canadian Medical Association
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
2 hours ago
- Cision Canada
Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil
New five-year agreement delivers critical academic and life sciences insights into more than 400 institutions, broadening access and driving national research excellence LONDON, June 2, 2025 /CNW/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the renewal of its multi-year partnership with CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), significantly expanding access to trusted Academia & Government and Life Sciences & Healthcare data across over 400 Brazilian institutions. As compared to the previous contract, the agreement increases institutional coverage by 57%, extending the reach of high-quality research tools to universities and research centers across Brazil — from major metropolitan areas to the country's most remote regions. As a key agency under Brazil's Ministry of Education, CAPES plays a vital role in advancing postgraduate education, supporting high-level training, and fostering international scientific collaboration. A long-standing partner to CAPES, Clarivate began its collaboration with the agency in 2001, when the Web of Science became one of the first databases integrated into the CAPES Portal. This new agreement builds on that legacy, delivering enhanced access to solutions including Web of Science, Journal Citation Reports, Cortellis Drug Discovery Intelligence and Derwent Innovation Index. By bringing together world-class data and insights from academic research and the life sciences and healthcare sectors, the agreement empowers researchers and practitioners at all levels — including scholars, policy advisors, biomedical scientists and healthcare professionals — to conduct innovative research, develop new treatments, improve patient care, and inform policy decisions. It provides broad access to critical information, advancing evidence-based discovery, education and decision-making across disciplines. Matti Shem Tov, Chief Executive Officer, Clarivate, said:"This expanded partnership with CAPES is a powerful example of how strategic collaboration can accelerate research and innovation on a national scale. Brazil has made remarkable progress in advancing scientific excellence and global collaboration. We're proud to support this momentum by providing trusted data, insights, and technology to researchers across the country — from early discovery through impact assessment. Our shared commitment to expanding access and fostering innovation will continue to shape the future of research in Brazil and beyond." Denise Pires de Carvalho, President, CAPES, said: "Brazil is experiencing a moment of growing scientific output beyond its major urban centers, with resources now being distributed in a more equitable and democratic way to boost productivity across all regions. This collaboration with Clarivate enables us to better understand the scientific production profile of Brazilian institutions and supports more informed investment decisions to reduce regional disparities, which remains a significant national challenge. Many researchers in the North, Northeast and Center-West have limited access to the resources needed to give visibility to their work and expanding that access can make a meaningful difference." The renewed partnership reflects a shared commitment to democratizing access to critical scientific information and enabling data-driven research excellence. Through Web of Science, Journal Citation Reports, and Derwent Innovation Index, academic institutions and government agencies gain deeper visibility into global research trends, publication impact, and innovation pathways — supporting policy development, institutional benchmarking, and scholarly advancement. Complementing these capabilities, expanded access to Cortellis Drug Discovery Intelligence equips Brazil's life sciences community — including postgraduate students, faculty, and biomedical researchers — with comprehensive insights across biology, pharmacology, and chemistry. From disease understanding and drug interactions to clinical studies and intellectual property, users can more efficiently navigate the full R&D lifecycle and accelerate decision-making in high-impact research areas. By significantly expanding access to trusted research and innovation tools, this agreement supports CAPES' mission to reduce regional disparities and foster inclusive academic excellence. Institutions from across Brazil — from leading urban universities to those in underserved and remote regions — can now leverage high-quality data to strengthen postgraduate programs, accelerate innovation, and elevate the global visibility of Brazilian research. Clarivate values its collaboration with CAPES on this initiative to help shape a more connected, informed and future-ready research ecosystem across Brazil, and stands as a resource for academic consortia worldwide seeking to expand access to trusted research, data and insights. To learn more about this partnership and the solutions now available to CAPES institutions, visit here. Notes to editors According to the most recent Institute for Scientific Information G20 research and innovation scorecard: Around 40% of Brazilian research output is internationally collaborative, with many strong bilateral partnerships with the United States. It also participates in larger collaborations involving the U.S., the U.K., Spain, Germany, and France. Compared with other internationally collaborative output, these partnerships are producing papers with above average impact. Its research output shows a strong focus on Sustainable Development Goals (SDGs) Zero Hunger (SDG 2) and Life on Land (SDG 15), with impact for both around 0.7 to 0.8 times the world average. More broadly, Brazilian research output has a strong focus on the Life Sciences, while its output in Medicine has impact around 1.1 times the world average. Around 40% of output is published in open access (OA) journals, with their Humanities and Languages output 2.4 times more likely to be published in an OA journal than the G20 average. About Clarivate Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit About Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) is a consortium dedicated to expanding and strengthening postgraduate studies in Brazil. It ensures the quality of academic programs while fostering the development of highly qualified professionals in research, teaching, and other strategic scientific fields. Media contacts: Clarivate Catherine Daniel Director, External Communications – Life Sciences & Healthcare [email protected] CAPES João Mendes Communications [email protected] SOURCE Clarivate Plc
CTV News
5 hours ago
- CTV News
CTV National News: Canadians turn to AI for medical diagnoses
Watch As many Canadians don't have family doctors, some are turning to AI however the technology can be inaccurate at times. John Vennavally-Rao reports.
Vancouver Sun
15 hours ago
- Vancouver Sun
Son MAiD pioneer Kay Carter plans assisted death after terminal cancer diagnosis
Price Carter is planning to die this summer. The 68-year-old has been diagnosed with stage 4 pancreatic cancer. He knows it will take his life eventually; before it does, he intends to die on his own terms with his family at his side. 'I was told at the outset, 'This is palliative care, there is no cure for this.' So that made it easy,' he said in an interview from his home in Kelowna, B.C. Carter said he's always known that medical assistance in dying would be an option 'that I would exercise if I could, if needed to.' Start your day with a roundup of B.C.-focused news and opinion. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Sunrise will soon be in your inbox. Please try again Interested in more newsletters? Browse here. He has that option, in large part, because of his mother. Kay Carter's name is on the landmark Supreme Court of Canada case that gave Canadians the right to choose a medically assisted death just over a decade ago. Price has finished a first assessment and said he expects the second assessment deeming him eligible for the procedure to be completed this week. He spoke openly and calmly about his final days and his decision to end his life. 'I'm at peace with this, I truly am, and I would have been years ago,' he said. It's been nearly a year since he first started experiencing symptoms and got a diagnosis. Until a couple of months ago, he said, he was swimming and rowing. He and his wife Danielle went golfing recently, playing best ball. 'She dragged me down that course,' he said with a laugh. But his energy is starting to fade. He knows how he wants the next step to unfold. It was more than 15 years ago that Price, along with his sisters Marie and Lee and his brother-in-law Hollis, surreptitiously made their way to Switzerland to be with their mother on her final day. The 89-year-old was living with spinal stenosis and chose to go to a non-profit facility that provided medically assisted death. She became the 10th Canadian to do so. At the time, assisted death was illegal in Canada. Kay Carter wrote a letter explaining her decision and her family helped draft a list of about 150 people to send it to after she died. She couldn't tell them her plans in advance because of the risk that Canadian authorities would try to stop her from going to Switzerland, or prosecute the family members who helped her. When she got to the Dignitas facility, she finalized the paperwork, settled in a bed and chased down the barbiturate that would stop her heart with Swiss chocolate. 'When she died, she just gently folded back,' Price said. After a few minutes, one of the attendants from the facility walked over to the door, 'and the curtains billow out, and she says, 'There, her spirit is free,'' he said. 'If I was writing the movie, I wouldn't change that.' He said the memory makes him cry today, though not from sadness. The cancer, and the treatment, have made him emotional — the experience itself was beautiful. 'I wish for my children that they can see my death like I did my mom's,' he said. He said wants his wife, Danielle, and his kids to be there. His children — Lane, Grayson and Jenna — live in Ontario. They're all busy, he said, so when the time is right he'll try to find a date that works for everyone. For now, he's doing a lot of reading. 'I'm just gonna keep hanging on, day by day, and enjoying my Danielle.' We're all going to die. It's part of the condition of living. The Carter family had a long road after Kay's death in January 2010. Her eldest daughter Lee was the driving force behind taking the case to the Supreme Court, which issued a unanimous decision in early 2015 that struck down sections of the Criminal Code that made it illegal to help someone end their life. In 2016, the federal government passed legislation that created the country's regime for medical assistance in dying and made it legal for people whose deaths were 'reasonably foreseeable' to apply for an assessment. After a 2019 ruling in the Quebec Superior Court found it was unconstitutional to restrict assisted dying to people whose deaths were reasonably foreseeable, the Liberal government updated the law in 2021. That update included a controversial clause that would allow people suffering solely from a mental disorder to be considered eligible for an assisted death. The proposed change caused widespread worry among provinces and some mental health professionals, and has now been delayed until March 2027. In the meantime, Health Canada has been studying what Canadians think of allowing people to ask for medical assistance in dying through an advance request. Advance requests would allow people with Alzheimer's, dementia, or other degenerative conditions to make the application and decide when they'd like to end their lives. Price Carter said that change 'is such a simple thing to do.' 'We're excluding a huge number of Canadians from a MAID option because they may have dementia and they won't be able to make that decision in three or four or two years. How frightening, how anxiety-inducing that would be,' he said. He admitted to feeling frustrated at the pace of change, though he said he knows his 'laissez-faire' attitude toward death is uncommon. Helen Long, the president of Dying With Dignity Canada, said numerous federal consultations have shown there's broad support for advance requests dating back to 2016. 'We're continuing to advocate and ask our new government … to make advance requests legal for Canadians,' she said. Quebec has passed legislation to allow people with serious and incurable illnesses to apply for a medically assisted death in the event that they become incapacitated through an advance request. Marjorie Michel, who was recently named health minister in Prime Minister Mark Carney's new government, said in an interview that it's a question of balance. 'It's so personal for people, and I think in some provinces they are not there yet,' she said. But when asked if the government plans to allow advance requests, she deferred to her colleague in the Justice Department. A spokesperson for Justice Minister Sean Fraser said Michel would be best positioned to respond. Health Canada is set to release a report with the key findings from its consultations on the matter this spring. Medical assistance in dying is becoming more common in Canada. In 2023, the latest year for which national statistics are available, 19,660 people applied for the procedure and just over 15,300 people were approved. More than 95 per cent of those were people whose deaths were considered reasonably foreseeable. Price Carter said he wants to talk about his condition because he wants Canadians to talk about death, as uncomfortable as it is. 'The more conversations we can spawn around kitchen tables, the better,' he said. 'We're all going to die. It's part of the condition of living. And yet we do ignore this, to our peril.' Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our daily newsletter, Posted, here .
